Zoekresultaten - 1 result
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the DAWn-Plasma trial.
Publication Type: Peer reviewed scientific article Authors: Timothy Devos; Tatjana Geukens; Alexander Schauwvlieghe; Ariën, Kevin K; Cyril Barbezange; Myriam Cleeren; Veerle Compernolle; Nicolas ...